Herbal treatment for acute pancreatitis within 48 hours
Part of Digestive system clinical trials.
This trial is testing a herbal medicine (Dachaihu Decoction compound and rhubarb) for people with acute pancreatitis soon after symptoms start. It may help some patients by aiming to improve recovery when treatment begins early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You were diagnosed with acute pancreatitis using standard (Western) criteria within 48 hours of when your symptoms began.
- You can sign an informed consent form to join the study.
- You are not pregnant and not breastfeeding.
- You do not have certain urgent belly problems (like bowel blockage or a perforation) or a serious bile duct infection with pus.
- You do not have serious past or ongoing heart, liver, or kidney disease, and you do not have a mental illness or cancer.
- You do not have known allergies to the herbal ingredients or related medicine ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how severe acute pancreatitis works by using advanced tests on your body's germs, chemicals, and proteins. It may help find better ways to treat patients with this condition.
This study tests whether taking a specific friendly bacterium (Bifidobacterium longum) can help people with moderate-to-severe acute pancreatitis recover faster. Participants will either receive the bacterium or a placebo (inactive pill) for the first few days of treatment.
This trial tests a supplement called tributyrin (related to butyrate) to see if it can help prevent complications from acute pancreatitis when given early after diagnosis. It is for people having their first episode of pancreatitis, not for those with certain causes or weakened immune systems.
This trial tests infliximab (an anti-inflammatory medicine) versus placebo to see if it improves outcomes in adults with newly diagnosed acute pancreatitis. It is designed for treatment to start within 36 hours of hospital admission.
This trial compares starting with an early carbohydrate drink versus a clear liquid diet for people with mild or moderately severe acute pancreatitis. The goal is to see which approach helps recovery and is easier to tolerate.
This trial tests a single injection of a new drug called RABI-767, given through a thin tube during an endoscopic ultrasound (EUS), to see if it can help people with severe acute pancreatitis. The drug is meant to reduce inflammation and prevent complications.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.